SibelBlauMD

Oncology • Puyallup, WA

Breast Cancer, Hematologic Oncology, Thoracic Cancer

Medical Director at Rainier Hematology-Oncology, NWMS

Join to view full profile

Dr. Blau is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Blau's full profile

Already have an account?

Office
2940 S Meridian
Ste 100
Puyallup, WA 98373

Education & Training

Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1997
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1990 - 1993
OtherClass of 1987

Certifications & Licensure

OH State Medical License 1992 - 2026
WA State Medical License 1999 - 2026
American Board of Internal Medicine Medical Oncology

Clinical Trials

ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer Study Start of enrollment: 2023 May 19
Recruiting
Phase 2
Roles: Principal Investigator, Contact

Publications & Presentations

PubMed

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study.
Gayathri Nagaraj, Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M Kuderer
Elife. 2023-10-17
9 citations
XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormon...
Peter Schmid, Javier Cortes, Ana Joaquim, Noelia Martínez Jañez, Serafín Morales
Breast Cancer Research. 2023-06-12
1 citations
Operational Metrics for the ELAINE 2 Study Combining a Traditional Approach With a Just-in-TIME Model.
Sibel Blau, Julio Antonio Peguero, Halle C F Moore, Ian Churchill Anderson, Minal A Barve
JCO Clinical Cancer Informatics. 2023-06-01

Press Mentions

Jvion Drives Adoption of Prescriptive Intelligence and Clinical AI with New Peer-Reviewed Results, Platform Integrations and SDOH SolutionsSeptember 10th, 2021
Quality Cancer Care Alliance and ConcertAI Partner on Novel Digital Clinical Trial Solutions, Accelerating Patient Access to Clinical TrialsAugust 31st, 2021
Oncologists Remind Washingtonians: It’s Time to Screen for CancerJuly 31st, 2021